Realizing the benefits of tumour-agnostic access requires a national health learning system

Nature Reviews Clinical Oncology 2026

View at publisher

Authors: Samuel X. Stevens, Deme John Karikios

DOI: 10.1038/s41571-026-01167-6

Cited by: 1

References: 3

Fields of Study & Subjects

Health Systems Economic Evaluations Quality of Life Biomedical Ethics and Regulation Cancer Immunotherapy and Biomarkers

References 3